Cerebellar Hypoplasia in Two Juvenile African Grey Parrots (Psittacus erithacus).

Two sibling 12-week-old DNA-sexed female African grey parrots (Psittacus erithacus) were presented for progressive whole-body tremors, proprioceptive deficits, and an inability to stand unassisted. A third bird in the clutch (DNA-sexed as a male) exhibited no clinical signs. Physical examination of the affected birds revealed ataxia, inability to stand without assistance, and a reliance on their beaks to assist with their mobility. Hematologic and biochemical analyses were normal, as were radiographic images of both birds. Cerebellar disease of unknown origin was diagnosed, and the birds were euthanized. Postmortem examinations of the brains of both parrots revealed marked reduction in cerebellar size and poor folia formation. Microscopic review of the cerebellums demonstrated decreased density of the granular layer and thinning of the molecular layer with poorly organized and differentiated Purkinje fibers, consistent with a diagnosis of cerebellar hypoplasia. There are limited clinical reports and experimental studies examining cerebellar disease in birds. Conditions described have included cerebellar hypoplasia, cerebellar abiotrophy, and cerebellar dysplasia. Although these terms are used interchangeably due to similar clinical signs, histopathology is needed to differentiate between the different disease conditions. This case describes cerebellar hypoplasia that suggested a developmental etiology in 2 African grey parrots.

Polycystic Kidney Disease in 3 Juvenile Rainbow Lorikeets (Trichoglossus moluccanus).

This case series describes polycystic kidney disease in 3 (2 male, 1 female) 2-month-old, juvenile rainbow lorikeets (Trichoglossus moluccanus). The lorikeets diagnosed with polycystic kidney disease were the progeny of full sibling parents that were being intentionally line bred for the purpose of establishing a rainbow lorikeet with the blue color mutation. Clinically the juvenile lorikeets were presented with clinical signs of lethargy, dehydration, regurgitation, anorexia, polyuria, and pelvic limb paresis. Multiple abnormalities were identified on the complete blood count and plasma biochemistry panel, including a normocytic normochromic nonregenerative anemia, hyperuricemia, hyperphosphatemia, hypercalcemia, and azotemia. Severe renal dysfunction was diagnosed in all birds on the basis of clinical presentation, physical examination, and complete blood count and plasma biochemistry results. Radiographically marked renomegaly was noted in one of the cases. Although intensive critical care and supportive therapy was provided, 1 lorikeet died, and the remaining 2 were euthanatized because of client financial constraints and a rapid deterioration of their clinical condition associated with severe renal dysfunction. Postmortem pathology results found that all birds had marked renomegaly, visceral gout, and polycystic kidney disease. Because of the age of the birds and the line breeding within this group of lorikeets, the disease was believed to be inherited. Polycystic kidney disease should be considered as a possible differential diagnosis in juvenile psittacine birds with a history of line breeding when presented with severe renal dysfunction. From the current case series, polycystic kidney disease appears to carry a grave prognosis in juvenile rainbow lorikeets.

Induction of General Anesthesia With Alfaxalone in the Domestic Chicken.

Alfaxalone is a safe and effective anesthetic drug for the induction of general anesthesia in many nonavian companion animal species; however, its efficacy has not been fully evaluated in birds. In premedicated trials, the chickens were sedated with butorphanol 2 mg/kg intramuscularly and midazolam 0.5 mg/kg intramuscularly, 15 minutes before intravenous administration of alfaxalone. The chickens were classified as anesthetized if endotracheal intubation was achieved without eliciting a cough reflex, provoking no patient resistance, and with minimal glottis movement within 15 seconds after the administration of alfaxalone. Qualitative and quantitative data were recorded, including duration of anesthesia, quality of induction, quality of recovery, reflexes, time to sternal recumbency, time to standing, and time to normal behaviors. Survival analysis was used to analyze the association between alfaxalone dosage and premedication with time-related variables. Out of the evaluated doses, the lowest intravenous alfaxalone dose required to achieve anesthetic induction and endotracheal intubation in unpremedicated and premedicated chickens was 7.5 and 4 mg/kg, respectively. The duration of anesthesia for all dose rates within the study ranged from 51 seconds to 4 minutes 45 seconds. Premedication generally improved the quality of induction and recovery, but significantly (P < .001) increased the time required for the chickens to stand after being anesthetized and to return to normal behaviors. Most chickens exhibited varying degrees of hyperactivity on anesthetic induction and recovery. No postinduction apnea or deaths of the subject birds occurred during this investigation.